Intricate Molecular Machinery and Detailed Understanding of Cellular Components Structure Revolutionizing Cryo-electron Microscopy Market

Cryo-electron Microscopy Market
Cryo-electron Microscopy Market

Cryo-electron microscopy (Cryo-EM) is becoming a cornerstone in drug discovery and development. With its high-resolution images of biomolecules, cryo-electron microscopy has changed the research landscape, offering detailed molecular structures crucial for advancing therapeutic interventions. Its constant evolution, marked by improved detectors, automated data collection, and sophisticated image processing software, enhances accessibility and applicability across diverse research areas, expanding its scope beyond structural biology to fields like materials science, chemistry, and nanotechnology.

Investments in life sciences research from both public and private sectors have propelled the cryo-electron microscopy market forward, leading to the development of cutting-edge instruments. The applications of cryo-electron microscopy have grown exponentially, attracting interest and investments from various scientific disciplines. Collaborations between academic institutions, research organizations, and industry players have played a pivotal role in accelerating the adoption of cryo-electron microscopy. These collaborations have facilitated the establishment of cryo-electron microscopy facilities and led to shared resources and knowledge exchange, contributing significantly to market growth.

Request a Sample of this Report:
https://www.fmisamplereport.com/sample/rep-gb-18841

However, despite cryo-electron microscopy’s revolutionary impact, challenges persist in the market. Cryo-electron microscopy instruments’ significant initial and ongoing costs pose barriers for smaller research institutions with limited budgets. The technology’s technical complexity may result in a need for more skilled personnel, hindering widespread adoption.

Traditional techniques like X-ray crystallography and nuclear magnetic resonance spectroscopy compete with cryo-electron microscopy based on cost and speed. Regulatory challenges, infrastructure demands, and the need for specialized facilities also present hurdles.

“The crucial role of cryo-electron microscopy software in handling massive datasets and its continuous evolution make it an integral part of the cryo-electron microscopy ecosystem, facilitating collaboration and knowledge exchange within the scientific community.” says an analyst

Key Takeaways from the Market Study

  • Software products are estimated to dominate the market, with a growth of 11.3% in the forecast period.
  • Transmission electron microscopy technology accounts for a compound annual growth rate of 11.2%.
  • The market for cryo-electron microscopy in South Korea is expected to evolve at a remarkable CAGR of 13.5% through 2034.
  • The cryo-electron microscopy market in China is predicted to rise at a whopping 11.8% CAGR through 2034.
  • The cryo-electron microscopy market in the United States has the potential to increase at 11.4% CAGR through 2034.
  • The market for cryo-electron microscopy in Japan is estimated to rise by 12.2% CAGR through 2034.
  • The cryo-electron microscopy market in the United Kingdom is projected to capture a CAGR of 12.1% through 2034.

Competitive Landscape

Thermo Fisher Scientific Inc. is a leading player in the market and offers a comprehensive range of Cryo-EM solutions, including instruments, software, and consumables. The company invests heavily in research and development to enhance the performance and capabilities of its products.

Olympus Corporation, OPTIKA, Helmut Hund Gmbh, Labindia Instruments, and JEOL Ltd. contribute to the market’s development by providing cutting-edge instruments, technologies, and support services. These companies are crucial in advancing Cryo-EM technology, making it more accessible and effective for scientists worldwide. For instance, JEOL installed two Transmission Electron Microscopes, the CRYO ARM 200 and CRYO ARM 300, at Biomedicines in Andover, the United States, in 2023. These cutting-edge microscopes can capture atomic-resolution details for drug discovery in oncology, immunology, and other infectious diseases.

Market Segmentation

By Product:

  • Software
  • Services
  • Instrument
    • Fully Automated Instruments
    • Semi-Automated Instruments

By Technology:

  • Transmission Electron Microscopy
  • Scanning Electron Microscopy
  • Cryo-Electron Tomography
  • Nuclear Magnetic Resonance Microscopy
  • Others

By Application:

  • Cancer Research
  • Nanotechnology
  • Cell and Gene Therapy
  • Vaccines
  • Life Sciences Research and Academic
  • Toxicology Studies
  • Preclinical and Clinical Studies
  • Healthcare

By Region:

  • Asia Pacific
  • Europe
  • North America
  • The Middle East & Africa
  • Latin America

Author:

Sudip Saha is the managing director and co-founder at Future Market Insights, an award-winning market research and consulting firm. Sudip is committed to shaping the market research industry with credible solutions and constantly makes a buzz in the media with his thought leadership. His vast experience in market research and project management a consumer electronics will likely remain the leading end-use sector cross verticals in APAC, EMEA, and the Americas reflects his growth-oriented approach to clients.

He is a strong believer and proponent of innovation-based solutions, emphasizing customized solutions to meet one client’s requirements at a time. His foresightedness and visionary approach recently got him recognized as the ‘Global Icon in Business Consulting’ at the ET Inspiring Leaders Awards 2022.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Airway Clearance Devices System Market Projected to Reach USD 1,137.2 Million by 2033, Growing at a CAGR of 6.2%

Global Airway Clearance Devices System Market
Global Airway Clearance Devices System Market

The global airway clearance devices system market is set to experience robust growth over the next decade. Valued at USD 624.5 million in 2023, the market is projected to expand at a compound annual growth rate (CAGR) of 6.2%, reaching an estimated USD 1,137.2 million by 2033.

This growth is primarily driven by the rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma. The increasing awareness about the benefits of airway clearance devices in managing these conditions, along with technological advancements in device development, are key factors contributing to the market’s expansion.

When used in conjunction with respiratory therapy, airway clearance devices help patients with bronchiectasis, cystic fibrosis, and chronic obstructive pulmonary disease (COPD) by efficiently eliminating mucus and enhancing lung function. To mobilize and remove secretions from the airways, these devices use a variety of techniques, including mechanical percussion, oscillatory positive expiratory pressure (OPEP), and high-frequency chest wall oscillation (HFCWO).

Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5230

In order to maximize outcomes and enhance the patient experience, stakeholders in the respiratory treatment sector are concentrating on innovation, education, and patient-centered care as the global healthcare landscape changes. Airway clearance medicine availability can be increased globally by manufacturers and healthcare providers addressing unmet requirements through investments in clinical evidence collecting, patient support programs, and research and development.

Key Drivers of Market Growth:

  • Rising Prevalence of Respiratory Disorders: The increasing number of individuals diagnosed with cystic fibrosis, chronic obstructive pulmonary disease (COPD), and bronchiectasis is driving the demand for airway clearance devices.
  • Technological Advancements: Medical device companies are continually innovating and developing more user-friendly and effective airway clearance devices. For instance, Project Fizzyo, a collaboration between Microsoft, Great Ormond Street Hospital, and University College London, gamifies cystic fibrosis treatment, making it more engaging for children.
  • Improved Patient Outcomes: Airway clearance devices effectively remove mucus, leading to reduced lung infections and improved lung function for patients.

Competitive Landscape:

To increase their market share significantly, most businesses take part in joint research projects, market expansions, and strategic acquisitions. Allergan plc, Dymedso Inc., Electromed Inc., Ltd., General Physiotherapy Inc., Hill-Rom Holdings, Inc., International Biophysical Corporation, Koninklijke Philips N.V. (Philips), Monaghan Medical Corporation, Inc., PARI GmbH, and Thayer Medical are a few of the well-known companies in the global market for airway clearance devices.

Recent Developments:

  • In May 2022, AbbVie, a research-based global biopharmaceutical company, announced that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court.
  • In 2021, Baxter International, a renowned MedTech leader, announced that it had completed the acquisition of Hillrom. Baxter paid US$ 156 in cash for each outstanding share of Hillrom common stock for a purchase price of US$ 10.5 million. Including the assumption of Hillrom’s outstanding debt obligations, the enterprise value of the transaction is about US$ 12.5 million
  • Thayer Medical has introduced the Quake airway clearance device for people suffering from mucus-producing respiratory conditions. The product delivers comprehensive and convenient secretion clearance therapy that has an easy-to-use, portable, and handheld design.
  • Monaghan Medical Corporation has added its oscillating positive expiratory pressure device named Aerobika. This helps in clearing the lungs and serves people with conditions like COPD, cystic fibrosis, and bronchitis

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-5230

Key Segmentation:

By Product Type:

  • Positive Expiratory Pressure
  • Intrapulmonary Percussive Ventilation
  • Oral High-Frequency Oscillation
  • High-Frequency Chest Wall Oscillation
  • Flutter
  • Incentive Spirometry

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Key Regions Covered:

  • North America
    • The United States
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • The United Kingdom
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Japan
  • Asia Pacific Excluding Japan
    • China
    • India
    • Malaysia
    • Singapore
    • Australia
    • Rest of Asia Pacific Excluding Japan (APEJ)
  • The Middle East and Africa
    • GCC Countries
    • Israel
    • South Africa
    • The Middle East and Africa (MEA)

In-Depth Market Overview: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/5230

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Amblyopia Treatment Market to Reach USD 5,582.3 Million by 2033, Growing at a CAGR of 3.8%

Amblyopia Treatment Market
Global Amblyopia Treatment Market

The global amblyopia treatment market is poised for significant growth over the next decade. Valued at USD 3,837.2 million in 2023, the market is expected to expand at a compound annual growth rate (CAGR) of 3.8%, reaching USD 5,582.3 million by 2033.

Amblyopia, commonly known as “lazy eye,” is a vision development disorder where an eye fails to achieve normal visual acuity, typically due to poor early visual experience. The market growth is driven by increasing awareness about early diagnosis and treatment, advancements in treatment technologies, and the rising prevalence of amblyopia among children.

Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5039

A few instances of how amblyopia treatment technologies and therapies are developing, expanding the range of accessible treatments and improving patient outcomes, are novel patching techniques, interactive visual games, and virtual reality-based therapies. These developments aim to improve the efficacy, engagement, and adherence of amblyopia treatment regimens by catering to the diverse needs of patients across a range of age groups.

Competitive Landscape:

Vivid Vision, 3M, Lancastle International Ltd., Johnson & Johnson, Trayner, Good-Lite, HOYA Vision Care Company, Ortopad USA, NovaSight, and Revital Vision are a few of the major players in the worldwide amblyopia treatment market.

Due to the existence of multiple prominent players, there is intense competition in this industry. Although a few of global players, including Vivid Vision, 3M, and Lancastle International Ltd., account for a sizeable portion of the market, other regional players are also active in important growing regions, most notably Asia Pacific.

Recent Developments :

  • In November 2020, RevitalVision announced the release of a new web vision training software application with RevitalVision’s new branding. This advanced software, which is designed to improve vision by improving the brain’s visual processing, is easier to use and provides better patient feedback.
  • In October 2021, HOYA Vision Care announced a partnership with Orbis International, a global organization that mentors, trains, and inspires local eye care professionals to save sight in their communities. This strategic partnership marks a significant step in HOYA’s Corporate Social Responsibility (CSR) program, which is aimed at bridging the vision care gap around the world.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-5039

Key Companies Profiled:

  • Vivid Vision
  • 3M
  • Lancastle International Ltd
  • Johnson and Johnson
  • Trayner
  • Good-Lite
  • HOYA Vision Care Company
  • Ortopad USA
  • NovaSight
  • Revital Vision

Key Segments Covered in the Market Report:

By Treatment Type :

  • Eye Patches
  • Spectacle Lenses
  • Eye Drops & Ointments
  • Surgery
  • Other Amblyopia Treatment

By Distribution Channel :

  • Pharmacies
  • Drug Stores
  • Hypermarkets and Supermarkets
  • E-Commerce

By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • The Middle East & Africa (MEA)

In-Depth Market Overview: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/5039

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Analytical Laboratory Service Market Set for Exponential Growth, Expected to Reach US$ 1,375.0 Million by 2034

The global analytical laboratory service market is poised to cross US$ 472.6 million in 2024 and is likely to attain a valuation of US$ 1,375.0 million by 2034. The analytical laboratory service industry is projected to expand at a CAGR of 11.3% from 2024 to 2034.

Adopting data analytics and digital technology in analytical labs represents a fundamental change in operating procedures. This trend optimizes data analysis, interpretation, and decision-making processes using artificial intelligence and machine learning algorithms. Analytical laboratories that use these technologies satisfy the changing needs of data-driven companies by increasing productivity, accuracy, and gaining a competitive edge in providing accurate and comprehensive results.

In analytical laboratories, automating sample preparation is a calculated step that can enhance operational efficiency, minimize human error, and simplify operations. By implementing cutting-edge automation technology, laboratories can save money, enhance throughput, and improve repeatability. In terms of corporate strategy, investment in automated advanced sample preparation is consistent with an emphasis on resource efficiency and operational excellence. Faster turnaround times brought about by the simplified procedures enable laboratories to satisfy customer expectations effectively, get a competitive advantage, and hold a dominant position in the market for analytical laboratory services.

Request a Sample of this Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-18834

The rise of new sectors, such as cannabis testing, electric car battery testing, and cell-based meat manufacturing, generates the need for specialized testing services. Analytical laboratories that adapt and invest in knowledge relevant to these growing sectors have the potential to become significant players in specialized markets with strong growth rates.

Key Takeaways from the Analytical Laboratory Service Market Report

  • The bioanalytical testing segment is predicted to develop at an 11.1% CAGR through 2034.
  • The hospital-based laboratories segment is expected to thrive at a 10.8% CAGR through 2034.
  • The market size in the United States is projected to increase at an 11.6% CAGR through 2034.
  • The market size in the United Kingdom is anticipated to develop at a 12.5% CAGR through 2034.
  • The market size in Japan is estimated to surge at a 12.8% CAGR through 2034.
  • The market size in South Korea is expected to thrive at a 13.1% CAGR through 2034.

Competitive Landscape

The analytical laboratory service market is intensely competitive, with leading global competitors such as Eurofins, SGS, and Bureau Veritas leading with broad service portfolios. Niche players focus on specialized testing areas, whereas startups drive innovation. Strategic expansion often involves mergers, acquisitions, and collaborations. Regulatory compliance and accreditation are critical differentiators that ensure reliability. Customer interactions and service quality are extremely important. The dynamic market is developing in response to technology improvements and regulatory changes, presenting obstacles and possibilities for organizations seeking to gain prominence.

Note from the Analysts

“Customer-centric strategies, innovation, legal compliance, and collaborative efforts are critical to success in the highly competitive market for analytical laboratory services. Managing fluctuating market expectations and trends requires sustainability, adaptation, and imaginative problem-solving. In order to succeed in this changing environment, businesses must prioritize customer demands, embrace innovation, maintain legal compliance, build strategic partnerships, commit to sustainability, and demonstrate flexibility.” Says an FMI analyst.

Request for Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-18834

Recent Developments

  • In October 2023, Cal State LA and LECO Corporation, a laboratory equipment enterprise, recently collaborated to establish the LECO Complex Chemical Compositional Analysis Lab. The new lab, housed in the restored laboratory area of Rosser Hall on the Cal State LA campus, will serve as a hub for students, institutional colleagues, and industry partners to research complicated chemical samples.
  • In July 2023, Recipharm, a worldwide CDMO, opened a new analytical facility in Bengaluru, India, to extend its testing capabilities for elemental impurities, extractables, leachables, and nitrosamines.

Analytical Laboratory Service Market Segmentation

By Test Type:

  • Bioanalytical Testing
  • Batch release Testing
  • Method Validation
  • Raw Material Testing
  • Microbial Testing
  • Physical Characterization
  • Stability Testing
  • Environmental Monitoring

By Service Type:

  • Hospital-Based Laboratories
  • Stand-alone Laboratories
  • Clinics-Based Laboratories

By Method Type:

  • Pharmacokinetic Testing
  • Biomarker Testing
  • Virology Testing
  • Cell-Based Assays
  • Immunogenicity
  • Serology

By Application:

  • Oncology
  • Neurology
  • Infectious Disease
  • Cardiology
  • Gastroenterology
  • Others

By Technology:

  • Mass Spectroscopy
  • Immunochemistry
  • UPLC Technology
  • Turbulent Flow Technology
  • Others

By End User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Development and Manufacturing Organizations
  • Contract Research Organizations
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)
  • Japan

Click to Buy Your Exclusive Report Immediately! https://www.futuremarketinsights.com/checkout/18834

Author:

Sudip Saha is the managing director and co-founder at Future Market Insights, an award-winning market research and consulting firm. Sudip is committed to shaping the market research industry with credible solutions and constantly makes a buzz in the media with his thought leadership. His vast experience in market research and project management a consumer electronics will likely remain the leading end-use sector cross verticals in APAC, EMEA, and the Americas reflects his growth-oriented approach to clients.

He is a strong believer and proponent of innovation-based solutions, emphasizing customized solutions to meet one client’s requirements at a time. His foresightedness and visionary approach recently got him recognized as the ‘Global Icon in Business Consulting’ at the ET Inspiring Leaders Awards 2022.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

USA Skilled Nursing Facility Market Projected to Reach USD 251.94 Billion by 2032 at a 3.32% of CAGR

USA Skilled Nursing Facility Market
USA Skilled Nursing Facility Market

The USA skilled nursing facility market in the USA is forecasted to experience steady growth over the next decade. Valued at USD 181.74 billion in 2022, the market is expected to expand at a compound annual growth rate (CAGR) of 3.32% from 2022 to 2032, reaching an anticipated valuation of USD 251.94 billion by 2032.

The growth of the skilled nursing facility market is driven by several factors, including the aging population, increasing prevalence of chronic diseases, and the growing need for specialized care services. Skilled nursing facilities provide essential healthcare services, including rehabilitation, long-term care, and post-operative care, catering primarily to the elderly and those requiring continuous medical supervision.

Skilled nursing facilities are essential to the healthcare continuum because they offer patients specialized care and rehabilitation services for both acute and long-term medical issues. These institutions provide patients recovering from surgery, managing chronic diseases, or moving from hospital care to a home environment with comprehensive medical, rehabilitative, and long-term care services.

Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15268

Stakeholders in the US skilled nursing facility market are focusing on innovation, quality improvement, and patient-centered care in order to enhance service delivery and outcomes. By funding initiatives linked to technology integration, staff development, and care coordination, skilled nursing institutions can increase patient satisfaction, maximize efficiency, and optimize the delivery of care.

Challenges and Adaptations

The COVID-19 pandemic undeniably impacted the skilled nursing facility market, with initial restrictions on admissions due to concerns about infection outbreaks. However, the industry has shown resilience by implementing innovative solutions:

  • Infection Control Technologies: Skilled nursing facilities have adopted wireless videoconferencing technologies to facilitate communication between patients, families, and staff while minimizing infection risks.

  • Improved Patient Experience: Facilities are increasingly providing internet access in patient rooms, enhancing communication and overall patient experience.

Looking Ahead: A Sustainable Market:

The financial stability of skilled nursing facilities is greatly reliant on the availability of government healthcare programs such as Medicare and Medicaid. Furthermore, the increased prevalence of chronic illnesses, especially cardiovascular disease—which, according to the American Heart Association, affects nearly 82.6 million Americans—highlights the ongoing necessity for these specialized care facilities.

What Effect Has Competition Had on the US Market for Skilled Nursing Facilities?

Because there are numerous local enterprises, the market for skilled care facilities in the United States is fragmented. Companies are diversifying the services they offer. Maintaining competitive prices is another challenge.

Some of the key market players are Life Care Services; Golden Living Centres; Life Care Centres of America Corporate; Peninsula Behavioral Health; Sava Senior Care Administrative Services LLC; Lincare, Inc. Genesis Healthcare; Brookdale Senior Living Solutions; The Ensign Group; Inc; Extendicare; Sunrise Senior Living; LLC; Life Care Services; Golden Living Centres; Life Care Centres of America Corporate; Peninsula Behavioral Health; Sava Senior Care Administrative Services LLC; Lincare, Inc.

These players in the US skilled nursing facility market are constantly working on new product development, employing various strategies such as mergers and acquisitions, partnerships, collaborations, and more.

Recent Development:

Acquisition:

  • Amedisys announced the acquisition of Contessa Health, a leading hospital, and skilled care facility company, in June 2021. The company hopes to expand its home care capabilities through this acquisition by adding more advanced acute care home hospitals and skilled home care facilities with advanced analytics platforms and expanding network management.
  • In December 2020, The Ensign Group, Inc. purchased Hays Nursing and Rehabilitation Center, a 116-bed skilled nursing facility in Texas.

Expansion:

  • Approximately 10,293 nursing facilities had received Paycheck Protection Program loans totaling approximately US $ 5.7 billion by March 2021. This program was created as part of the CARES Act and was expanded by the Consolidated Appropriations Act, of 2021, to help businesses retain employees during the pandemic.

Contract:

  • In February 2021, OMEGA Healthcare signed a US $ 150 million contract with HealthPeak Property to acquire Brookdale Senior Living in the United States.

Partnership:

  • Genesis Healthcare announced a real estate partnership with Next Health Capital in February 2019 that will involve 15 SNFs. This strategy will help the SNF expand its presence and cater to more patients.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-15268

Key Players:

  • Genesis Healthcare
  • Brookdale Senior Living Solutions
  • Lincare, Inc.
  • The Ensign Group, Inc
  • Extendicare
  • Sunrise Senior Living, LLC
  • Life Care Services
  • Golden Living Centers
  • LifeCare Centers of America Corporate
  • Peninsula behavioral health
  • Sava Senior Care Administrative Services LLC

Key Segments:

By Type:

  • Freestanding
  • Hospitals

By Ownership:

  • For-Profit
  • Non-Profit
  • Government

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Explore In-Depth Market Insights: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/15268

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Increasing Preferring for Fresh and Locally Sourced Products and a Focus on Sustainable Agriculture Practices Driving the Demand for Commercial Greenhouses

Picture background

In 2024, the market for commercial greenhouses is projected to be worth USD 44.6 billion. With a compound annual growth rate (CAGR) of 11.9% from 2024 to 2034, the commercial greenhouse market is expected to reach USD 137 billion. The market is expanding because to the rising need for controlled environment agriculture and sustainable food production. Precision farming is in high demand due to year-round production, crop diversity, and the need for local and fresh supplies. Customers also desire energy-efficient and ecologically friendly solutions. Intelligent controls and automated systems are examples of advanced technology that is highly after.

Customers in the commercial greenhouse industry primarily favor solutions that focus on the environment and energy efficiency. Producers are turning toward developments in automated systems and intelligent controls to accomplish precision farming. But they require more than simply cutting-edge technology. They also need solutions that support crop diversity, allow for year-round production, and can satisfy the demand for fresh products in the area. An emphasis on quality, sustainability, and innovation characterizes the extremely active commercial greenhouse sector.

Request a Sample of this Report:
https://www.fmisamplereport.com/sample/rep-gb-18823

The commercial greenhouse industry is witnessing a notable upswing in its growth trajectory, primarily due to the rapidly rising attention given to year-round production and crop diversification. This has led to an increased adoption of advanced greenhouse technologies and innovative farming techniques to improve crop yields and quality. Furthermore, these measures have also been designed to minimize the adverse environmental impacts of traditional agricultural practices. The industry is presently experiencing a surge in demand for various crops, including vegetables, fruits, flowers, and ornamental plants. This trend has opened up fresh opportunities for greenhouse growers and suppliers worldwide.

The demand for commercial greenhouses might be decreasing because of the economic downturns affecting agricultural investments. Furthermore, the shift in consumer preferences toward outdoor farming and traditional methods could also lead to a drop in demand. Emerging challenges, like changing market dynamics or external factors such as climate and disease, may also contribute to declining demand for commercial greenhouses.

“The commercial greenhouse industry is experiencing growth due to the growing demand for sustainable food production and controlled environment agriculture. Customers value environmentally friendly solutions, precision farming, and advanced technology. The industry is focusing on quality, sustainability, and innovation, with a surge in demand for various crops. However, economic downturns, consumer preferences, and emerging challenges may impact demand.” Says Lead Analyst at FMI

Key Takeaways from the Commercial Greenhouse Market 

  • The United States commercial greenhouse industry is projected to experience a CAGR of 7% through 2034.
  • Japan commercial greenhouse market is expected to demonstrate a rapid CAGR of 4% through 2034.
  • The United Kingdom commercial greenhouse industry is anticipated to witness a CAGR of 6% through 2034.
  • South Korean commercial greenhouse industry showcases a promising CAGR of 2% through 2034.
  • China commercial greenhouse market is expected to display an astonishing CAGR of 8% through 2034.

Competitive Landscape

Key market players in greenhouse farming are expanding and standardizing best practices. They prioritize sustainability by adopting eco-friendly practices and promoting resource-efficient technologies. Influential companies educate stakeholders about commercial greenhouses’ benefits, driving acceptance. Investment in research and development contributes to advanced greenhouse solutions and crop varieties.

Leading players drive the adoption of innovative technologies like precision farming and automation, shaping the industry’s modernization. Collaborations with technology providers, agricultural research institutions, and government bodies facilitate knowledge exchange, driving industry growth. Prominent players also advocate for supportive policies at national and international levels, influencing regulatory frameworks that impact the commercial greenhouse industry’s growth.

Recent Developments in the Commercial Greenhouse Market

  • In January 2024, Centuria Capital Group acquired a greenhouse and glasshouse facility within the Adelaide Plains, South Australia, for its open-ended, unlisted agriculture fund from horticulture group P’Petual Holdings.
  • In January 2024, Lassana Agri cultivated 10,000 hectares using advanced greenhouse solutions to uplift farmers from poverty by transitioning them to modern agriculture and providing predictive revenue models to secure financial support for expanding production.
  • In October 2023, VidaWool affiliated with Hawthorne Gardening to distribute nutrient-optimizing indoor horticulture products, including strings, plugs, blocks, and slabs.

Key Segments

By Equipment Type:

  • Heating Systems
  • Cooling Systems
  • Other

By Crop Type:

  • Fruits and Vegetables
  • Flowers and Ornamentals
  • Nursery Crops
  • Others

Greenhouse Type:

  • Glass Greenhouses
  • Plastic Greenhouse

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa

Author:

Sudip Saha is the managing director and co-founder at Future Market Insights, an award-winning market research and consulting firm. Sudip is committed to shaping the market research industry with credible solutions and constantly makes a buzz in the media with his thought leadership. His vast experience in market research and project management a consumer electronics will likely remain the leading end-use sector cross verticals in APAC, EMEA, and the Americas reflects his growth-oriented approach to clients.

He is a strong believer and proponent of innovation-based solutions, emphasizing customized solutions to meet one client’s requirements at a time. His foresightedness and visionary approach recently got him recognized as the ‘Global Icon in Business Consulting’ at the ET Inspiring Leaders Awards 2022.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Electromyography Devices Market Poised for Strong Growth, Expected to Reach USD 1,753 Million by 2033 at a 6.8% of CAGR

Global Electromyography Devices Market
Global Electromyography Devices Market

The global electromyography devices market is set for substantial growth over the next decade, with its valuation projected to increase from USD 908 million in 2023 to USD 1,753 million by 2033. This growth trajectory reflects a robust compound annual growth rate (CAGR) of 6.8% from 2023 to 2033.

The anticipated expansion of the EMG devices market is driven by several key factors, including the rising prevalence of neuromuscular disorders, increasing adoption of advanced diagnostic technologies, and growing awareness of the benefits of early diagnosis and treatment. EMG devices play a critical role in diagnosing and monitoring conditions that affect muscle health and nerve function, making them essential tools in modern medical practice.

Electromyography (EMG) devices are a valuable diagnostic and therapeutic tool for neuromuscular disorders because they give clinicians important insights into the anatomy and physiology of muscles and nerves. By identifying the electrical activity produced by muscular contractions, these devices let medical professionals assess nerve transmission, identify anomalies, and track the course of disorders.

Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-3971

Advancements in technology within the field of electromyography are contributing to enhancements in therapy accuracy, patient comfort, and accessibility. These advancements include, for instance, the development of wireless, portable, and user-friendly technologies. These developments facilitate the ability of healthcare providers to do EMG examinations at several sites, hence aiding in the prompt identification and management of neuromuscular disorders.

Rising Demand for Neuromuscular Disorder Diagnosis

The primary cause of this development is the rising incidence of neuromuscular conditions such ALS, myopathy, motor neuron illnesses, myasthenia gravis, and Parkinson’s disease. The market for EMG devices is predicted to grow as less invasive operations become more common in the diagnosis and treatment of various disorders.

There is no denying these illnesses have a substantial worldwide impact. The Global Institute for Health Metrics and Evaluation estimates that approximately 237,000 people died from motor neuron disease alone in 2017. In a similar vein, the Parkinson’s disorder Foundation states that the disorder affects over 10 million people globally. The market for EMG devices is being driven ahead in large part by the increasing prevalence of neuromuscular illnesses.

Technological Advancements and Portability Drive Innovation

The industry is additionally stimulated by the continuous progress in EMG technology. For example, the introduction of portable EMG devices permits greater simplicity of usage and flexibility. The RS-EMGX EMG system is one example of such innovation; it enables the simultaneous recording of four channels of EMG from a single participant. It is expected that these technological advancements would have a major impact on market growth in the upcoming years.

Key Takeaways from the Electromyography (EMG) Devices Market:

  • The United States market leads the North American electromyography devices market in terms of market share in North America. The United States held a leading market share of 35.7% in 2022. The factors attributed to the growth are world-class healthcare systems, higher technological penetration in healthcare systems, higher bandwidth internet, and integration of smart technologies. The North American region held a market share of 38.4% of the global market in 2022.
  • The German electromyography devices market held a healthy market share of 11.1% in 2022. The market growth is caused by the government’s focus on public health and innovation. The increasing geriatric population is also putting healthcare authorities on their toes to upgrade their systems with the recent versions. The European region accounted for a fair share of 29.2% of the global EMG devices market in 2022.
  • The Indian market thrives at a healthy CAGR of 7.8% between 2023 and 2033. The growth is attributed to the country building new multi-specialty hospitals and renovating their healthcare systems.
  • China’s electromyography market thrives at a CAGR of 8.3% between 2023 and 2033.
  • Based on modality, the standalone devices lead the segment as it held a market share of 71.1% in 2022.
  • Based on end-user type, the hospital segment aces the category as it held a market share of 42.1% in 2022.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-3971

Market Competition:

Compumedics Limited, Cadwell Laboratories Inc., Covidien Limited, Electrical Geodesics Inc., Natus Medical Inc., Nihon Kohden America Inc., NeuroWave Systems Inc., and Noraxon U.S.A.; Inc. are key participants in the worldwide electromyography devices market.

Recent Developments

  • In February 2021, Cadwell acquired Sleepmate Sleep Diagnostic Sensors from Ambu A/S. Cadwell is a pioneer in neurodiagnostic and neuromonitoring solutions.
  • In July 2020, Magtism, the global leader in Transcranial Magnetic Stimulation (TMS), announced an agreement to acquire the product portfolio of Electrical Geodesics Inc. from Royal Philips. Magtism acquired EGI hardware, sensor net assets, and software and handle global sales.
  • Nihon Kohden America Inc. has introduced its EMG/NCV/EP measuring desktop system with a six or twelve-channel amplifier and up to two electrical stimulators.

Key Players:

  • Compumedics Limited
  • Cadwell Laboratories Inc.
  • Covidien Limited
  • Electrical Geodesics Inc.
  • Natus Medical Inc.
  • Nihon Kohden America Inc.
  • NeuroWave Systems Inc.
  • Noraxon U.S.A. Inc.

Key Segments Covered:

By Modality:

  • Portable
  • Standalone

By End User:

  • Clinics
  • Hospitals
  • Rehabilitation Centers
  • Homecare Centers

By Region:

  • North America
    • United States
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Japan
  • Asia Pacific Excluding Japan
    • China
    • India
    • Malaysia
    • Singapore
    • Australia
    • Rest of Asia Pacific Excluding Japan (APEJ)
  • The Middle East and Africa
    • GCC Countries
    • Israel
    • South Africa
    • Middle East and Africa (MEA)

In-Depth Market Analysis: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/3971

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Drug Discovery Enzymes Market Set for Robust Growth, Projected to Reach USD 1,751.3 Million by 2033 at a 6.5% of CAGR

Drug Discovery Enzymes
Global Drug Discovery Enzymes Market

The global drug discovery enzymes market is on track for significant growth over the next decade, with its value expected to rise from USD 932.4 million in 2023 to USD 1,751.3 million by 2033. This market expansion represents a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2023 to 2033.

This marks an acceleration compared to the preceding period from 2018 to 2022, during which the market experienced a CAGR of 4.2%. The enhanced growth trajectory can be attributed to several factors, including advancements in biotechnology, increased investment in pharmaceutical research and development, and the rising prevalence of chronic diseases that drive the demand for new and effective drugs.

In the identification, validation, and improvement of therapeutic targets and candidates, enzymes are essential tools in pharmaceutical research and development. These enzymes aid in the discovery of novel treatments for a range of diseases, expedite the drug development process, and clarify metabolic pathways.

Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4340

Several reasons are driving the expected expansion of the drug discovery enzymes market globally. Investments in drug discovery research and development are being driven by the rising incidence of infectious and chronic diseases, as well as the rising need for novel therapies and customized medicine strategies. The market is growing due to the prospective applications and capabilities of drug discovery enzymes being expanded by innovations in enzymology, protein engineering, and high-throughput screening methods.

Broadening Horizons: Enzymes Drive Innovation Across Industries

This growth is explained by the increasing adoption of drug discovery enzymes by a greater number of companies. These enzymes have historically been used in the biotechnology and pharmaceutical industries, but they are also being used in the food and beverage sectors. This pattern illustrates a common emphasis on using enzymes for a variety of analyses, which eventually results in the creation of ground-breaking drugs.

Beyond Pharmaceuticals: Enzymes for a Sustainable Future

Drug discovery enzymes have applications outside of the pharmaceutical industry. Producing intermediates for the synthesis of active pharmaceutical ingredients (APIs) is proving to be crucial to the development of potent drugs. In addition, the biofuel sector has made use of the potential of enzymes such as lipase. These enzymes are essential for the conversion of free fatty acids, which emphasizes the wide range of industries that have used this technology.

Unlocking a Healthier Future

The market for drug discovery enzymes is booming, which bodes well for the advancement of medicine. We can expect the development of more specialized and potent drugs as long as research and development on enzymes continue. This means better healthcare outcomes, but it also shows how enzymes can transform a number of industries and open the door to a future powered by ground-breaking discoveries.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-4340

Competitive Analysis of the Drug Discovery Enzymes Market:

In recent years, a number of well-known researchers have focused on studying drug discovery enzymes. In recent years, pharmaceutical experts have developed a number of pharmacological enzymes that have assisted in the treatment of patients’ life-threatening illnesses.

Some recent developments in the Drug Discovery Enzymes industry are as follows:

  • In November 2020-Genesis Therapeutics and Genentech formed an AI-driven, multi-target drug development cooperation. Genesis’ graph machine learning and drug discovery capabilities are used in this cooperation to uncover novel drug candidates for therapeutic targets across numerous disease categories.
  • In January 2020, Bayer signed a collaborative deal with the artificial intelligence drug discovery business Exscientia to develop and optimize innovative lead structures for prospective therapeutic candidates in the treatment of cardiovascular and oncological illnesses.

Some Key Participants Present in the Global Market Include:

  • Sigma-Aldrich Co. LLC.
  • Kaneka Corporation
  • Actelion Pharmaceuticals Ltd
  • Genesis Biotechnology Group
  • Suven Life Sciences Limited
  • Enzo Life Sciences, Inc.
  • Merck KGaA

Key Segments:

By Product Type:

  • Active Kinases
  • Ubiquitin
  • Epigenetic
  • Methyltransferases
  • Deacetylases
  • Phosphodiesterases
  • Other Product Types

By End User:

  • Pharmaceutical and Biotechnology Company
  • Research Institutes
  • Other End User

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East and Africa
  • Europe

In-Depth Market Analysis: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/4340

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global DNA Sequencing Services Market Poised for Significant Growth, Expected to Reach USD 2,080.2 Million by 2033 at a 8.2% of CAGR

DNA Sequencing Services Market
Global DNA Sequencing Services Market

The global DNA sequencing services market is projected to witness substantial growth over the next decade, with its valuation anticipated to soar from USD 945.6 million in 2023 to USD 2,080.2 million by 2033. This impressive expansion is forecasted at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2033.

The primary driver of this growth is the increasing incidence of cancer worldwide. As the prevalence of cancer continues to rise, so does the demand for advanced DNA sequencing services. These services are critical for the early detection, diagnosis, and treatment of various forms of cancer, enabling personalized medicine approaches that improve patient outcomes.

DNA sequencing services are essential to the science of genomics because they allow the examination of genetic material and the finding of variations, mutations, and biomarkers associated with a range of illnesses, including cancer. These services cover a wide range of sequencing techniques and processes and provide doctors, researchers, and pharmaceutical companies with valuable information on the genetic causes of diseases and tailored treatment plans.

Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-6453

The key factor propelling the anticipated expansion of the worldwide market for DNA sequencing services is the increasing prevalence of cancer worldwide. As the number of cancer patients worldwide rises, so does the need for precision medical procedures and cutting-edge genetic technology to improve diagnosis, prognosis, and treatment outcomes. The capacity of researchers and clinicians to identify cancers, identify potential therapeutic targets, and develop customized treatment plans based on individual genetic profiles is driving the use of DNA sequencing services in oncology.

DNA Sequencing: Unlocking the Secrets Within

The order of the four building units of DNA—adenine (A), thymine (T), guanine (G), and cytosine (C)—can be determined via DNA sequencing, a potent technology. Interestingly, A and C always pair with T and G, respectively. Deciphering the base pair sequence is essential to obtaining an individual’s genetic code. This information holds immense potential for various applications, including:

  • Identifying regulatory instructions within DNA
  • Pinpointing the location of genes
  • Understanding the genetic underpinnings of diseases

Top Highlights from the FMI’s Analysis of the DNA Sequencing Services Market:
•The North American region is expected to account for the leading market share of more than 40.6% in 2023, followed by Europe, which is projected to account for 32.4% in the same year.

•The United Kingdom is forecast to expand at a CAGR of 12.9% over the estimated period, suggesting significant business avenues that the country is expected to present.

•India is anticipated to record a CAGR of 8.5% over the forecast period, whereas China is forecast to propel at a CAGR of 7.8%. DNA sequencing services are expected to increase in the region to meet the increasing medical demands of the population.

•Japan is forecast to account for a market share of 2.7%, comparatively lower than the other competitive markets. However, the market is expected to offer diverse growth opportunities to businesses.

•Based on solutions and services, the data analysis and sequencing services segment is forecast to account for 41.8% of the global market.

•Under the end-user category, the academic institutes and research centers segment is anticipated to record more than 37.7% over the forecast period.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-6453

Market Competition:

Illumina Inc., Thermo Fischer Scientific Inc., Oxford Nanopore Technologies Plc, Agilent Technologies, Inc., QIAGEN, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ, Inc., Hamilton Company, Macrogen Inc., Zymo Research Corporation, and Tecan Trading AG are a few of the major players in the global DNA sequencing services market.

Owing to the involvement of multiple prominent players, the industry exhibits intense competition. International firms like Oxford Nanopore Technologies plc, Thermo Fischer Scientific Inc., and Illumina Inc. In addition to making up a sizeable portion of the market, a number of regional players are active in important growing areas, mainly in North America.

Recent Developments

  • In December 2020, Eurofins Genomics released SARS-CoV-2 NGS services that are both cost-effective and optimized, allowing for entire viral genome sequencing.
  • In May 2020, Roche introduced the KAPA Target Enrichment portfolio and the KAPA HyperExome whole-exome research panel for target enrichment during sequencing.
  • Illumina recently received Emergency Use Authorization (EUA) from the FDA for its COVIDSeq Test, which is used to sequence the entire genome of the novel SARS-CoV-2 virus.
  • Face2Gene LABS was launched in June 2019 by PerkinElmer, Inc. and FDNA, an artificial intelligence company, to provide genomic services in conjunction with Next-Generation Phenotyping (NGP) technologies for more accurate and efficient diagnoses.

Key Segments Profiled in The DNA Sequencing Services Industry Survey:

By Product Type:

  • Maxam–Gilbert DNA Sequencing
  • Chain-Termination Methods
  • Dye-Terminator Sequencing
  • Automation and Sample Preparation
  • Large-scale DNA Sequencing
  • New DNA Sequencing Methods
  • High Throughput DNA Sequencing
  • Parallel Signature Sequencing (MPSS)
  • Polony Sequencing
  • Pyrosequencing
  • Illumina (Solexa) Sequencing
  • SOLiD Sequencing
  • Others

By End Use:

  • Automotive Industry
  • Chemical Industry
  • Agriculture
  • Oil and Gas
  • Research and Development
  • Other End Uses

By Application:

  • Hospitals
  • Diagnostic Centers
  • Biotechnology and Pharmaceutical Industry
  • Academic Research Institutes
  • Other Application Areas

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East & Africa

Get Full Market Analysis Now: Purchase The Report:
https://www.futuremarketinsights.com/checkout/6453

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Demand for 5G Testing Equipment and Services Witnesses a Surge with Booming Telecom Sector. The Global 5G Testing Market Value to Reach US$ 7.8 billion by 2034 end.

The 5G testing market valuation was assessed to be around US$ 2.1 billion in 2019. During the historical period, the market expanded with a robust CAGR of 11.4%. In congruence with these numbers, the worth of the market in 2023 was figured out to be around US$ 3.2 billion.

In 2024, the global market for 5G testing is estimated to be nearly US$ 3.6 billion. The market research report hints the year-on-year growth in demand for 5G testing equipment and services is likely to be 8.2% through 2034. The research report further forecasts the worldwide 5G testing industry value to reach US$ 7.8 billion by 2034 end.

Request for a Sample of this Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-18807

“Rising demand for high-speed or low-latency mobile network services has surged the use of 5G network and testing services for its performance. As applications of 5G continue to increase with the advancement of smart devices, IoT, wearables, and linked devices, global 5G testing services are likely to grow steadily,” says an FMI analyst.

Key Takeaways

  • The United States, with leading 5G testing service providers, dominates the global market and is expected to advance further at 8.4% CAGR through 2034.
  • In Europe, the United Kingdom is currently the leading market for 5G network testing solutions and is likely to progress at 8.6% CAGR through 2034.
  • China, the pioneer of 5G technology in Asia, is expected to witness an expansion of its regional market at 9.2% CAGR between 2024 and 2034.
  • Japan follows China in the 5G testing equipment and solution market and is projected to follow a higher CAGR of 9.3% through the projected years.
  • South Korea is growing remarkably in 5G testing services in Asia currently, with an estimated CAGR of 9.5% till 2034.

Request for Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-18807

Competitive Landscape for the 5G Testing Market Participants

The market is highly fragmented as numerous players have cropped up with the 5G network devices and services expansion in the last few years. However, the 5G testing equipment segment is relatively consolidated as a few leading players have the capacity and capital to keep up with the market trends.

The leading 5G testing equipment manufacturers are putting a lot of effort into advancing the technology to remain competitive with the fast-evolving cellular network technologies. To secure their position, new market players are collaborating and partnering with 5G technology research and development institutes.

Recent Developments by the 5G Testing Industry Players

In May 2023, Tektronix Incorporation introduced the Double Pulse Test solution called WBGDPT to measure wide bandgap devices repeatedly and autonomously. Tektronix is a global supplier of test and measurement solutions, and the WBGPTD system is aimed at supporting significant developments in solar energy, electric cars, and industrial controls.

Anritsu Corp. and Artiza Networks Company teamed up in March 2023 to provide an Open RAN test solution to facilitate multi-vendor sourcing. The Open RAN idea leverages network point standards and the ongoing development of AI applications as a source of business opportunities.

Key Segments Covered by 5G Testing Industry Survey Report

By Offering:

  • Hardware
  • Services

By End-use Industries:

  • IDMs & ODMs
  • Telecom Equipment Manufacturers
  • Telecom Service Providers
  • Other End-use Industries

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia and Pacific
  • The Middle East and Africa (MEA)

Author:

Sudip Saha is the managing director and co-founder at Future Market Insights, an award-winning market research and consulting firm. Sudip is committed to shaping the market research industry with credible solutions and constantly makes a buzz in the media with his thought leadership. His vast experience in market research and project management a consumer electronics will likely remain the leading end-use sector cross verticals in APAC, EMEA, and the Americas reflects his growth-oriented approach to clients.

He is a strong believer and proponent of innovation-based solutions, emphasizing customized solutions to meet one client’s requirements at a time. His foresightedness and visionary approach recently got him recognized as the ‘Global Icon in Business Consulting’ at the ET Inspiring Leaders Awards 2022.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube